Tonix Pharma and Southern Research announced expansion of COVID-19 vaccine collaboration
On Jun. 18, 2020, Tonix Pharmaceuticals announced an expansion of its strategic collaboration with Southern Research to include…
ViralClear opened enrollment with first patient dosing in phase II human trial of anti-viral MMPD oral solution for treatment of COVID-19
On Jun. 17, 2020, BioSig Technologies, and its subsidiary, ViralClear, announced that it had commenced patient enrollment with…
The FDA warned of newly discovered potential drug interaction that may reduce effectiveness of COVID-19 treatment
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) warned health care providers about a newly…
The FDA revoked Emergency Use Authorization for chloroquine and hydroxychloroquine
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that…
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO
Batavia Biosciences and Valneva collaborated to accelerate development of low-cost inactivated polio vaccine
On Jun. 15, 2020, Batavia Biosciences and Valneva announced a collaboration agreement to accelerate market-access of a low-cost…
Mayo Clinic Study of Humanigen’s lenzilumab showed rapid recovery and discharged in severe and critical COVID-19 patients
On Jun. 15, 2020, Humanigen announced data on the first clinical use of lenzilumab in 12 COVID-19 patients….
BioCryst’s galidesivir stops Zika viral replication in primate model
On Jun. 11, 2020, BioCryst Pharmaceuticals announced new data published in Science Translational Medicine that show, in a…
Quidel received BARDA funding to develop point-of-care diagnostic assay that includes COVID-19
On Jun. 11, 2020, Quidel announced it had received funding from the Biomedical Advanced Research and Development Authority…
Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19
On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…
OraSure received BARDA funding for Coronavirus Antibody ELISA using oral fluid samples
On Jun. 10, 2020, OraSure Technologies announced it had been awarded a $629,217 contract from the Biomedical Advanced…
Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technology
On Jun. 8, 2020, Intravacc and Versatope announced that they have signed a research service agreement to further…
Unique biorepository stores samples from Alberta COVID-19 patients for future research
On Jun. 5, 2020, the Alberta Precision Laboratories (APL) COVID-19 Biorepository was announced to ensure researchers have the…
No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
On Jun. 5, 2020, the Chief Investigators of the randomised evaluation of COVid-19 thERapY (RECOVERY) trial on hydroxychloroquine…
ViralClear added St. David’s HealthCare to phase II trial for broad-spectrum oral anti-viral COVID-19 candidate
On Jun. 5, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma, announced it had expanded its patient enrollment…
Novavax awarded Department of Defense contract for COVID-19 vaccine
On Jun. 4, 2020, Novavax announced that the company had been awarded a contract by the U.S. Department…
Successful detailed tracking of major plant disease’s global spread
On Jun. 4, 2020, Agricultural Research Service scientists and their Oregon State University collaborators announced they had developed…
INOVIO and IVI Partnered with Seoul National University Hospital to start phase 1/2 clinical trial of COVID-19 DNA vaccine (INO-4800) in South Korea
On Jun. 4, 2020, INOVIO and Seoul National University Hospital announced a partnership to start a Phase 1/2…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Measles | Polio | Vaccine
World leaders made historic commitments to provide equal access to vaccines for all
On Jun. 4, 2020, world leaders pledged an additional US$ 8.8 billion for Gavi, the Vaccine Alliance, far…
Introduction and spread of SARS-CoV-2 in the greater Boston area
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
Emergent BioSolutions joined U.S. Government’s Warp Speed Program for COVID-19 vaccine development and manufacturing
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
Anixa Biosciences and OntoChem synthesized four potential Covid-19 drugs for testing in biological assays
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced they had synthesized four potential Covid-19 compounds that will…
Tonix Pharma announced FUJIFILM Diosynth Biotechnologies to be Manufacturing partner for COVID-19 vaccine candidate TNX-1800
On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and…
Moderna announced first participants in each age cohort dosed in phase 2 study of mRNA vaccine against novel Coronavirus
On May 29, 2020, Moderna announced the first participants in each age cohort had been dosed in the…
Novavax expanded large-scale global manufacturing capacity
On May 27, 2020, Novavax announced the acquisition of Praha Vaccines, part of the Cyrus Poonawalla Group, in…
Novavax initiated phase 1/2 clinical trial of COVID-19 vaccine
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
Biotechnology | COVID-19 | Disease | Infectious Disease | Measles | Polio | Therapeutics | Vaccine | WHO
At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupted routine vaccination efforts
On May 22, 2020, COVID 19 disrupted life-saving immunization services around the world, putting millions of children –…
University of British Columbia researchers developed biodegradable medical mask for COVID-19
On May 21, 2020, the BioProducts Institute at the University of British Columbia announced it had designed a…
INOVIO COVID-19 DNA vaccine INO-4800 demonstrated robust neutralizing antibody and T cell immune responses in preclinical models
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
Mammoth Biosciences collaborated with GSK to develop COVID-19 test using CRISPR-based platform
On May 20, 2020, Mammoth Biosciences announced a collaboration with GSK Consumer Healthcare to develop an accurate, easy-to-use,…
Rapid Micro Biosystems raised $120 million to accelerate global expansion of contaminant testing platform for pharmaceutical and vaccine manufacturing
On May 20, 2020, Rapid Micro Biosystems announced a $120 million financing round, led by equity investment from…